AC Immune S.A.ACIUNASDAQ
Loading
Gross Profit Growth Under PressureDecelerating
Percentile Rank23
Year-over-Year Change
Year-over-year gross profit growth rate
Latest
-28.10%
↓ 128% vs avg
Percentile
P23
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
101.58%
Historical baseline
| Period | Value |
|---|---|
| Q3 2025 | -28.10% |
| Q2 2025 | 31.92% |
| Q1 2025 | -12.93% |
| Q4 2024 | -95.54% |
| Q3 2024 | 3609.61% |
| Q2 2024 | 0.00% |
| Q1 2024 | -100.00% |
| Q4 2023 | 0.00% |
| Q3 2023 | 0.00% |
| Q2 2023 | 0.00% |
| Q1 2023 | 100.00% |
| Q4 2022 | -44.82% |
| Q3 2022 | 0.00% |
| Q2 2022 | 0.00% |
| Q1 2022 | 0.00% |
| Q4 2021 | 0.00% |
| Q3 2021 | 0.00% |
| Q2 2021 | 0.00% |
| Q1 2021 | 100.00% |
| Q4 2020 | -4.25% |
| Q3 2020 | -22.76% |
| Q2 2020 | -300.48% |
| Q1 2020 | 78.79% |
| Q4 2019 | -162.93% |
| Q3 2019 | 296.02% |
| Q2 2019 | -117.63% |
| Q1 2019 | 691.66% |
| Q4 2018 | -16.05% |
| Q3 2018 | -8.65% |
| Q2 2018 | 1.23% |
| Q1 2018 | -237.42% |
| Q4 2017 | 187.99% |
| Q3 2017 | -17.03% |
| Q2 2017 | -11.69% |
| Q1 2017 | 3.23% |
| Q4 2016 | 11.52% |
| Q3 2016 | -144.44% |
| Q2 2016 | 393.10% |
| Q1 2016 | 9.34% |
| Q4 2015 | -126.65% |